The levels of RAC3 expression are up regulated by TNF in the inflammatory response

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 450-457

  Alvarado, Cecilia Viviana ^a   Rubio, María Fernanda ^a,b   Fernández Larrosa, Pablo Nicolas ^a,b   Panelo, Laura Carolina ^a   Azurmendi, Pablo Javier ^a   Ruiz Grecco, Marina ^a   Martínez Nöel, Giselle Astrid ^a,b   Costas, Mónica Alejandra ^a,b  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Glucocorticoids; NF B; RAC3; TNF

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN; RAC PROTEIN; RAC3 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

EID: 84901231911     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.04.009     Document Type: Article

References (42)

1. Anzick S., Kononen J., Walker R., Azorsa D., Tanner M., Guan X., Sauter G., Kallioniemi O., Trent J., Meltzer P. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
2. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12:141-179.
3. Beck I.M., Vanden Berghe W., Vermeulen L., Yamamoto K.R., Haegeman G., De Bosscher K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr. Rev. 2009, 30:830-882.
4. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233:652-654.
5. Beutler B., Krochin N., Milsark I.W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986, 232:977-980.
6. Chen Q., Chen T., Xu Y., Zhu J., Jiang Y., Zhao Y., Xu J., Yu C. Steroid receptor coactivator 3 is required for clearing bacteria and repressing inflammatory response in Escherichia coli-induced septic peritonitis. J. Immunol. 2010, 185:5444-5452.
7. Chen Q., Chen T., Xu Y., Zhu J., Jiang Y., Zhao Y., Xu J., Yu C. Steroid receptor coactivator 3 is required for clearing bacteria and repressing inflammatory response in Escherichia coli-induced septic peritonitis. J. Immunol. 2012, 185:5444-5452.
8. Colo G.P., Rubio M.F., Nojek I.M., Werbajh S.E., Echeverria P.C., Alvarado C.V., Nahmod V.E., Galigniana M.D., Costas M.A. The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action. Oncogene 2008, 27:2430-2444.
9. Costas M., Trapp T., Pereda M.P., Sauer J., Rupprecht R., Nahmod V.E., Reul J.M., Holsboer F., Arzt E. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. J. Clin. Invest. 1996, 98:1409-1416.
10. Costas M.A., Muller Igaz L., Holsboer F., Arzt E. Transrepression of Nf-κB is not required for glucocorticoid-mediated protection of TNF-α induced apoptosis on fibroblast. Biochem. Biophys. Acta 2000, 1499:122-129.
11. Coste A., Louet J.F., Lagouge M., Lerin C., Antal M.C., Meziane H., Schoonjans K., Puigserver P., O'Malley B.W., Auwerx J. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17187-17192.
12. Dong R., Wang Q., He X.L., Chu Y.K., Lu J.G., Ma Q.J. Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz. J. Med. Biol. Res. 2007, 40:1071-1078.
13. Fernandez Larrosa P.N., Alvarado C.V., Rubio M.F., Ruiz Grecco M., Micenmacher S., Martinez-Noel G.A., Panelo L., Costas M.A. Nuclear receptor coactivator RAC3 inhibits autophagy. Cancer Sci. 2012, 103:2064-2071.
14. Fujita Y., Sakakura C., Shimomura K., Nakanishi M., Yasuoka R., Aragane H., Hagiwara A., Abe T., Inazawa J., Yamagishi H. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 2003, 50:1857-1863.
15. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl):S81-S96.
16. Gnanapragasam V.J., Leung H.Y., Pulimood A.S., Neal D.E., Robson C.N. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br. J. Cancer 2001, 85:1928-1936.
17. Hench P.S., Slocumb C.H., et al. The effects of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone (Compound E) on the acute phase of rheumatic fever; preliminary report. Proceedings of the staff meetings. Mayo Clin. 1949, 24:277-297.
18. Henke R.T., Haddad B.R., Kim S.E., Rone J.D., Mani A., Jessup J.M., Wellstein A., Maitra A., Riegel A.T. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin. Cancer Res. 2004, 10:6134-6142.
19. Joyce D., Albanese C., Steer J., Fu M., Bouzahzah B., Pestell R.G. NF-kB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 2001, 12:73-90.
20. Li H., Gomes P.J., Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8479-8484.
21. Li H.J., Haque Z., Lu Q., Li L., Karas R., Mendelsohn M. Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation. Proc Natl Acad Sci U.S.A. 2007, 104:4065-4070.
22. Li C., Ao J., Fu J., Lee D.F., Xu J., Lonard D., O'Malley B.W. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1. Oncogene 2011, 30:4350-4364.
23. Li J., Liu Y.H., Ou S., Dai X.M., Wang J.P., Su Y.P. Steroid receptor coactivator-3 differentially regulates the inflammatory response in peritoneal macrophages. Mol. Med. Rep. 2012, 5:1099-1105.
24. Li J., Niu J., Ou S., Ye Z.Y., Liu D.Q., Wang F.C., Su Y.P., Wang J.P. Effects of SCR-3 on the immunosuppression accompanied with the systemic inflammatory response syndrome. Mol. Cell. Biochem. 2012, 364:29-37.
25. Liao L., Kuang S.Q., Yuan Y., Gonzalez S.M., O'Malley B.W., Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J. Steroid Biochem. Mol. Biol. 2002, 83:3-14.
26. Louie M.C., Revenko A.S., Zou J.X., Yao J., Chen H.W. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Mol. Cell. Biol. 2006, 26:3810-3823.
27. Ma G., Ren Y., Wang K., He J. SRC-3 has a role in cancer other than as a nuclear receptor coactivator. Int. J. Biol. Sci. 2011, 7:664-672.
28. Rubio M.F., Werbajh S., Cafferata E.G., Quaglino A., Colo G.P., Nojek I.M., Kordon E.C., Nahmod V.E., Costas M.A. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 2006, 25:1367-1377.
29. Rubio M.F, Fernandez P.N., Alvarado C.V., Panelo L.C., Grecco M.R., Colo G.P., Martinez-Noel G.A., Micenmacher S.M., Costas M.A. Cyclin D1 is a NF-kappaB corepressor. Biochim. Biophys. Acta 1823, 2012:1119-1131.
30. Saito M., Watanabe S. Differential modulation of lipopolysaccharide- and zymosan-induced hypophagia by dexamethasone treatment. Pharmacol. Biochem. Behav. 2008, 90:428-433.
31. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., Kimura A., Nakamura Y., Inazawa J., Abe T., Yamagishi H. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int. J. Cancer 2000, 89:217-223.
32. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987, 238:522-524.
33. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997, 387:677-684.
34. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., Sellers W.R., Brown M. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004, 6:263-274.
35. Wahl C., Liptay S., Adler G., Schmid R. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 1998, 101:1163-1174.
36. Wang C.Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787.
37. Wang Y., Wu M.C., Sham J.S., Zhang W., Wu W.Q., Guan X.Y. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002, 95:2346-2352.
38. Werbajh S., Nojek I., Lanz R., Costas M.A. RAC-3 is a NF-kappa B coactivator. FEBS Lett. 2000, 485:195-199.
39. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6379-6384.
40. Yan J., Tsai S.Y., Tsai M.J. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol. Sin. 2006, 27:387-394.
41. Yu C., York B., Wang S., Feng Q., Xu J., O'Malley B.W. An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response. Mol. Cell 2007, 25:765-778.
42. Zhou H.J., Yan J., Luo W., Ayala G., Lin S.H., Erdem H., Ittmann M., Tsai S.Y., Tsai M.J. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005, 65:7976-7983.